MHRA launches new Strategy for Improving Safety Communications on World Patient Safety Day: Improving information to patients and healthcare professionals

  • Post author:
  • Post category:

This World Patient Safety Day, 17 September 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) launches a new three-year Strategy for Improving Safety Communications, which aims to transform the…

Continue ReadingMHRA launches new Strategy for Improving Safety Communications on World Patient Safety Day: Improving information to patients and healthcare professionals

MHRA launches 2024/25 business plan with focus on enabling access to groundbreaking new technology while optimising delivery for all who need our services

  • Post author:
  • Post category:

As an Executive Agency of the Department of Health and Social Care, the MHRA have an important role in the delivery of the Government’s priorities to ensure people live healthier…

Continue ReadingMHRA launches 2024/25 business plan with focus on enabling access to groundbreaking new technology while optimising delivery for all who need our services

Statutory Instrument laid in Parliament provides first regulatory framework of its kind that will transform the manufacture of innovative medicines at the point of patient care

  • Post author:
  • Post category:

A Statutory Instrument (SI) laid in Parliament today, 21 October, will provide a new regulatory framework meaning that medicines with a very short shelf life and highly personalised medicines can…

Continue ReadingStatutory Instrument laid in Parliament provides first regulatory framework of its kind that will transform the manufacture of innovative medicines at the point of patient care

Statutory Instrument laid in Parliament sets out first steps in delivering Medical Device Regulatory Reform and strengthening patient safety

  • Post author:
  • Post category:

The Post-market Surveillance (PMS) Statutory instrument (SI) laid in Parliament yesterday evening is the first major update to the framework of medical device regulations in Great Britain, led by the…

Continue ReadingStatutory Instrument laid in Parliament sets out first steps in delivering Medical Device Regulatory Reform and strengthening patient safety

Donanemab licensed for early stages of Alzheimer’s disease in adult patients who have one or no copies of apolipoprotein E4 gene

  • Post author:
  • Post category:

Donanemab works by removing a sticky protein called beta-amyloid from the brain that is believed to cause Alzheimer’s disease, and in the trials conducted the medicine showed some evidence of…

Continue ReadingDonanemab licensed for early stages of Alzheimer’s disease in adult patients who have one or no copies of apolipoprotein E4 gene